Urticarial Vasculitis After First Denosumab Injection in an Osteoporotic Woman Diagnosed with Cushing’s Syndrome
Denosumab is a human-derived monoclonal immunoglobulin G2 antibody against the receptor activator of nuclear factor kappa B ligand, inhibiting the differentiation and function of osteoclast precursor cells by its antiosteoclastic action. Denosumab is approved for postmenopausal, glucocorti coid-indu...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Society of Endocrinology and Metabolism of Turkey
2022-09-01
|
| Colección: | Endocrinology Research and Practice |
| Materias: | |
| Acceso en línea: | https://endocrinolrespract.org/index.php/pub/article/view/1123 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|